Ligand Pharmaceuticals Incorporated
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2021
Total Assets: $1.30B
Liabilities Breakdown FY2021
Total Liabilities: $476.4M
Asset Breakdown
Total Assets: $1.30B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.5M | 1.5% |
| Accounts Receivable | $85.5M | 6.6% |
| Inventory | $27.3M | 2.1% |
| Property, Plant & Equipment | $13.2M | 1.0% |
| Goodwill | $105.7M | 8.1% |
| Intangible Assets | $376.7M | 29.0% |
| Other Assets | $669.7M | 51.6% |
Liabilities Breakdown
Total Liabilities: $476.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.4M | 1.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $468.0M | 98.2% |